Rosati Fabio sold $911K of XMTR (indirect holdings)

Rosati Fabio sold 10,000 indirectly-held shares of Xometry, Inc. (XMTR) at an average of $91.12 ($89.72–$93.42, $0.91M total) across 4 trades over 2026-08-10 to 2026-08-11.

Original reporting
SEC EDGAR · Rosati Fabio
Published Aug 11, 2026, 8:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale totaling $911,169.28 across four trades, with holdings after the sale of 91,667 shares.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone does not provide new operational or financial information.

03

What to watch

The article provides trade prices and share count but no reason for the sale, and insider sales often have non-informational motives.

Relevance 5/10Novelty 3/10Timing: Filed 2026-08-11 after-hours; reflects trades dated 2026-08-10 to 2026-08-11.

Background

The article is a SEC Form 4 insider transaction disclosure for Xometry, Inc. (XMTR).

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

Xometry director Rosati Fabio sold about 10,000 shares in open-market trades totaling $911,169, disclosed via Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief unless accompanied by other news.

Evidence & confidence

The filing is a routine Form 4 open-market sale by a director, with no 10b5-1 plan and no accompanying company guidance, deal, or operational change disclosed.

Market effects

Minimal; insider sales in a single name do not materially reset sector expectations.

None indicated.

None indicated.

Counterpoint

Because the sale is indirect and not tied to a disclosed 10b5-1 plan, it could be interpreted as liquidity-driven rather than bearish, limiting signal value.

Key entities

  • Xometry, Inc.

    Subject of the Form 4 insider transaction disclosure (XMTR).

  • Rosati Fabio

    Director who sold shares via open-market transactions; indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Xometry (XMTR) Q3 2026 Earnings Call Transcript

Xometry (XMTR) reported Q3 2026 revenue of $252M, up 40% YoY, with record gross margin and GAAP profitability. The company raised its full-year outlook, citing strong growth and AI-driven marketplace optimizations. It also announced a partnership with Siemens for integration into Designcenter, expected to launch in Q1 2027.

$XMTRMed

Xometry Inc (XMTR) Q3 2026 Earnings Call Highlights: Record Revenue, First GAAP Profit

Xometry Inc (XMTR) reported Q3 2026 revenue of $252M, up 40% YoY, and its first GAAP profit of $1.9M. Marketplace revenue grew 43% YoY, while services revenue lagged at 2% growth. The company raised its full-year 2026 revenue growth outlook to 37% and adjusted EBITDA guidance to $68-68.5M. Active buyers increased 20% YoY to over 93,000, but Q4 revenue growth is expected to decelerate to 32-33% YoY. Xometry continues to invest heavily in growth initiatives, with Q3 cash CapEx of $15M.

$XMTRHighAI 9/10

Why is Xometry stock surging today?

Xometry (XMTR) stock surged 15.8% after reporting Q3 revenue of $252.4M, up 40% YoY, and adjusted EPS of $0.28, beating estimates. The company achieved its first GAAP net income of $1.9M. Marketplace revenue grew 43%, and active buyers increased 20%. Xometry raised its full-year outlook and guided Q4 revenue to $254–$256M. The stock reached a new 52-week high of $117.50.